Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
PROTEOLYSIS |
31 |
1208 |
3.082e-13 |
1.434e-09 |
2 |
NOTCH SIGNALING PATHWAY |
12 |
114 |
1.601e-12 |
3.724e-09 |
3 |
REGULATION OF NOTCH SIGNALING PATHWAY |
10 |
67 |
3.492e-12 |
5.416e-09 |
4 |
POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY |
8 |
34 |
1.122e-11 |
1.044e-08 |
5 |
REGULATION OF CATABOLIC PROCESS |
23 |
731 |
1.112e-11 |
1.044e-08 |
6 |
PROTEIN MATURATION |
14 |
265 |
2.44e-10 |
1.893e-07 |
7 |
REGULATION OF PROTEOLYSIS |
21 |
711 |
3.163e-10 |
2.103e-07 |
8 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
34 |
1929 |
5.458e-10 |
2.619e-07 |
9 |
POSITIVE REGULATION OF CELL COMMUNICATION |
30 |
1532 |
6.579e-10 |
2.619e-07 |
10 |
POSITIVE REGULATION OF CATABOLIC PROCESS |
16 |
395 |
5.85e-10 |
2.619e-07 |
11 |
REGULATION OF PROTEIN CATABOLIC PROCESS |
16 |
393 |
5.434e-10 |
2.619e-07 |
12 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
24 |
983 |
6.755e-10 |
2.619e-07 |
13 |
POSITIVE REGULATION OF CELL DEATH |
19 |
605 |
8.963e-10 |
3.208e-07 |
14 |
EPHRIN RECEPTOR SIGNALING PATHWAY |
9 |
85 |
1.041e-09 |
3.461e-07 |
15 |
POSITIVE REGULATION OF PROTEOLYSIS |
15 |
363 |
1.607e-09 |
4.984e-07 |
16 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
17 |
498 |
2.187e-09 |
6.359e-07 |
17 |
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS |
13 |
263 |
2.498e-09 |
6.837e-07 |
18 |
REGULATION OF BINDING |
13 |
283 |
6.039e-09 |
1.561e-06 |
19 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
10 |
143 |
7.085e-09 |
1.735e-06 |
20 |
RESPONSE TO OXYGEN LEVELS |
13 |
311 |
1.857e-08 |
4.321e-06 |
21 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA |
6 |
32 |
2.055e-08 |
4.552e-06 |
22 |
REGULATION OF CELL DEATH |
27 |
1472 |
2.328e-08 |
4.924e-06 |
23 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
30 |
1791 |
2.486e-08 |
5.029e-06 |
24 |
NEUROGENESIS |
26 |
1402 |
3.618e-08 |
7.015e-06 |
25 |
RESPONSE TO ABIOTIC STIMULUS |
22 |
1024 |
3.917e-08 |
7.278e-06 |
26 |
REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
12 |
274 |
4.067e-08 |
7.278e-06 |
27 |
POSITIVE REGULATION OF ERBB SIGNALING PATHWAY |
6 |
36 |
4.337e-08 |
7.474e-06 |
28 |
ERROR PRONE TRANSLESION SYNTHESIS |
5 |
19 |
5.256e-08 |
8.734e-06 |
29 |
ERBB2 SIGNALING PATHWAY |
6 |
39 |
7.167e-08 |
1.15e-05 |
30 |
REGULATION OF RESPONSE TO STRESS |
26 |
1468 |
9.071e-08 |
1.407e-05 |
31 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
22 |
1079 |
9.813e-08 |
1.473e-05 |
32 |
POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
10 |
192 |
1.17e-07 |
1.702e-05 |
33 |
CELL CYCLE CHECKPOINT |
10 |
194 |
1.289e-07 |
1.818e-05 |
34 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
26 |
1517 |
1.732e-07 |
2.371e-05 |
35 |
GLYCOGEN BIOSYNTHETIC PROCESS |
5 |
25 |
2.338e-07 |
3.022e-05 |
36 |
GLUCAN BIOSYNTHETIC PROCESS |
5 |
25 |
2.338e-07 |
3.022e-05 |
37 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
17 |
689 |
2.478e-07 |
3.116e-05 |
38 |
REGULATION OF NECROTIC CELL DEATH |
5 |
26 |
2.882e-07 |
3.406e-05 |
39 |
CATABOLIC PROCESS |
28 |
1773 |
2.822e-07 |
3.406e-05 |
40 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
16 |
616 |
2.928e-07 |
3.406e-05 |
41 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
27 |
1672 |
3.136e-07 |
3.52e-05 |
42 |
CELLULAR RESPONSE TO STRESS |
26 |
1565 |
3.177e-07 |
3.52e-05 |
43 |
CARBOHYDRATE BIOSYNTHETIC PROCESS |
8 |
121 |
3.732e-07 |
4.038e-05 |
44 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
21 |
1087 |
4.893e-07 |
5.174e-05 |
45 |
POSITIVE REGULATION OF BINDING |
8 |
127 |
5.408e-07 |
5.592e-05 |
46 |
CELLULAR GLUCAN METABOLIC PROCESS |
6 |
58 |
8.163e-07 |
8.081e-05 |
47 |
GLUCAN METABOLIC PROCESS |
6 |
58 |
8.163e-07 |
8.081e-05 |
48 |
GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR |
5 |
32 |
8.593e-07 |
8.33e-05 |
49 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
8 |
139 |
1.075e-06 |
1e-04 |
50 |
SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE |
7 |
96 |
1.064e-06 |
1e-04 |
51 |
PROTEIN LOCALIZATION TO MEMBRANE |
12 |
376 |
1.212e-06 |
0.0001106 |
52 |
NOTCH RECEPTOR PROCESSING |
4 |
16 |
1.553e-06 |
0.000139 |
53 |
NEGATIVE REGULATION OF GENE EXPRESSION |
24 |
1493 |
1.792e-06 |
0.0001539 |
54 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
24 |
1492 |
1.771e-06 |
0.0001539 |
55 |
VIRION ASSEMBLY |
5 |
37 |
1.819e-06 |
0.0001539 |
56 |
REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS |
6 |
67 |
1.933e-06 |
0.0001606 |
57 |
MACROMOLECULAR COMPLEX ASSEMBLY |
23 |
1398 |
2.082e-06 |
0.0001699 |
58 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
19 |
1004 |
2.518e-06 |
0.000202 |
59 |
NEGATIVE REGULATION OF CYTOKINE PRODUCTION |
9 |
211 |
2.722e-06 |
0.0002147 |
60 |
CELL DEVELOPMENT |
23 |
1426 |
2.909e-06 |
0.0002256 |
61 |
ENERGY RESERVE METABOLIC PROCESS |
6 |
72 |
2.959e-06 |
0.0002257 |
62 |
TRANSLESION SYNTHESIS |
5 |
41 |
3.073e-06 |
0.0002306 |
63 |
POLYSACCHARIDE BIOSYNTHETIC PROCESS |
5 |
42 |
3.473e-06 |
0.0002407 |
64 |
ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS |
9 |
217 |
3.424e-06 |
0.0002407 |
65 |
ERROR FREE TRANSLESION SYNTHESIS |
4 |
19 |
3.266e-06 |
0.0002407 |
66 |
DNA SYNTHESIS INVOLVED IN DNA REPAIR |
6 |
74 |
3.477e-06 |
0.0002407 |
67 |
REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
8 |
162 |
3.393e-06 |
0.0002407 |
68 |
REGULATION OF CELL DEVELOPMENT |
17 |
836 |
3.518e-06 |
0.0002407 |
69 |
DNA METABOLIC PROCESS |
16 |
758 |
4.388e-06 |
0.0002959 |
70 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
22 |
1360 |
4.755e-06 |
0.0003161 |
71 |
CELL CELL SIGNALING |
16 |
767 |
5.095e-06 |
0.0003251 |
72 |
ERBB SIGNALING PATHWAY |
6 |
79 |
5.101e-06 |
0.0003251 |
73 |
DNA BIOSYNTHETIC PROCESS |
7 |
121 |
5.03e-06 |
0.0003251 |
74 |
GENERATION OF PRECURSOR METABOLITES AND ENERGY |
10 |
292 |
5.307e-06 |
0.0003337 |
75 |
POLYSACCHARIDE METABOLIC PROCESS |
6 |
80 |
5.49e-06 |
0.0003406 |
76 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
15 |
684 |
5.697e-06 |
0.0003488 |
77 |
NEGATIVE REGULATION OF CELL DEATH |
17 |
872 |
6.153e-06 |
0.0003624 |
78 |
MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS |
4 |
22 |
6.085e-06 |
0.0003624 |
79 |
NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING |
4 |
22 |
6.085e-06 |
0.0003624 |
80 |
REGULATION OF ERBB SIGNALING PATHWAY |
6 |
83 |
6.803e-06 |
0.0003908 |
81 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
9 |
236 |
6.771e-06 |
0.0003908 |
82 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
14 |
609 |
7.046e-06 |
0.0003998 |
83 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
10 |
303 |
7.343e-06 |
0.0004068 |
84 |
NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION |
4 |
23 |
7.335e-06 |
0.0004068 |
85 |
RESPONSE TO TOXIC SUBSTANCE |
9 |
241 |
8.018e-06 |
0.0004389 |
86 |
IMMUNE SYSTEM PROCESS |
27 |
1984 |
8.372e-06 |
0.0004529 |
87 |
EMBRYO DEVELOPMENT |
17 |
894 |
8.533e-06 |
0.0004564 |
88 |
NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING |
4 |
24 |
8.765e-06 |
0.0004634 |
89 |
NEGATIVE REGULATION OF TRANSPORT |
12 |
458 |
9.151e-06 |
0.0004713 |
90 |
MEMBRANE ORGANIZATION |
17 |
899 |
9.177e-06 |
0.0004713 |
91 |
CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS |
5 |
51 |
9.218e-06 |
0.0004713 |
92 |
REGULATION OF CELL ADHESION |
14 |
629 |
1.015e-05 |
0.0005134 |
93 |
REGULATION OF NEURON DEATH |
9 |
252 |
1.147e-05 |
0.0005737 |
94 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
17 |
917 |
1.188e-05 |
0.0005844 |
95 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
25 |
1784 |
1.193e-05 |
0.0005844 |
96 |
POSTREPLICATION REPAIR |
5 |
54 |
1.225e-05 |
0.0005936 |
97 |
MITOTIC CELL CYCLE CHECKPOINT |
7 |
139 |
1.252e-05 |
0.0005994 |
98 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
18 |
1021 |
1.262e-05 |
0.0005994 |
99 |
RESPONSE TO ENDOGENOUS STIMULUS |
22 |
1450 |
1.313e-05 |
0.0006112 |
100 |
REGULATION OF DNA BINDING |
6 |
93 |
1.313e-05 |
0.0006112 |
101 |
NEGATIVE REGULATION OF CATALYTIC ACTIVITY |
16 |
829 |
1.346e-05 |
0.0006201 |
102 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
25 |
1805 |
1.459e-05 |
0.0006527 |
103 |
PROTEIN LOCALIZATION |
25 |
1805 |
1.459e-05 |
0.0006527 |
104 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
15 |
740 |
1.451e-05 |
0.0006527 |
105 |
POSITIVE REGULATION OF KINASE ACTIVITY |
12 |
482 |
1.523e-05 |
0.000675 |
106 |
NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY |
4 |
28 |
1.66e-05 |
0.0007219 |
107 |
NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY |
4 |
28 |
1.66e-05 |
0.0007219 |
108 |
DNA INTEGRITY CHECKPOINT |
7 |
146 |
1.724e-05 |
0.0007427 |
109 |
CARBOHYDRATE METABOLIC PROCESS |
14 |
662 |
1.797e-05 |
0.0007534 |
110 |
INTERSPECIES INTERACTION BETWEEN ORGANISMS |
14 |
662 |
1.797e-05 |
0.0007534 |
111 |
SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM |
14 |
662 |
1.797e-05 |
0.0007534 |
112 |
NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY |
4 |
29 |
1.918e-05 |
0.0007967 |
113 |
PROTEIN CATABOLIC PROCESS |
13 |
579 |
1.966e-05 |
0.0008097 |
114 |
PROTEASOMAL PROTEIN CATABOLIC PROCESS |
9 |
271 |
2.042e-05 |
0.0008335 |
115 |
CELL PROLIFERATION |
14 |
672 |
2.122e-05 |
0.0008585 |
116 |
MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY |
4 |
30 |
2.203e-05 |
0.0008837 |
117 |
SOMITOGENESIS |
5 |
62 |
2.419e-05 |
0.0009539 |
118 |
SYNAPTIC SIGNALING |
11 |
424 |
2.415e-05 |
0.0009539 |
119 |
CEREBRAL CORTEX DEVELOPMENT |
6 |
105 |
2.628e-05 |
0.001027 |
120 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
22 |
1518 |
2.667e-05 |
0.001034 |
121 |
MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY |
4 |
32 |
2.866e-05 |
0.001091 |
122 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
14 |
691 |
2.883e-05 |
0.001091 |
123 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
19 |
1192 |
2.871e-05 |
0.001091 |
124 |
REGULATION OF CELL CYCLE ARREST |
6 |
108 |
3.083e-05 |
0.001157 |
125 |
ESTABLISHMENT OF PROTEIN LOCALIZATION |
21 |
1423 |
3.223e-05 |
0.001199 |
126 |
CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY |
4 |
33 |
3.248e-05 |
0.001199 |
127 |
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
7 |
162 |
3.369e-05 |
0.001234 |
128 |
CELLULAR CATABOLIC PROCESS |
20 |
1322 |
3.615e-05 |
0.001263 |
129 |
CELL DEATH |
17 |
1001 |
3.632e-05 |
0.001263 |
130 |
AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS |
3 |
12 |
3.529e-05 |
0.001263 |
131 |
OXIDATION REDUCTION PROCESS |
16 |
898 |
3.564e-05 |
0.001263 |
132 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
15 |
801 |
3.636e-05 |
0.001263 |
133 |
REGULATION OF TYPE I INTERFERON PRODUCTION |
6 |
111 |
3.599e-05 |
0.001263 |
134 |
SINGLE ORGANISM CELLULAR LOCALIZATION |
16 |
898 |
3.564e-05 |
0.001263 |
135 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
13 |
616 |
3.74e-05 |
0.001289 |
136 |
NUCLEOTIDE EXCISION REPAIR |
6 |
113 |
3.98e-05 |
0.001362 |
137 |
NEURON APOPTOTIC PROCESS |
4 |
35 |
4.12e-05 |
0.001389 |
138 |
MEMBRANE PROTEIN PROTEOLYSIS |
4 |
35 |
4.12e-05 |
0.001389 |
139 |
REGULATION OF PROTEIN BINDING |
7 |
168 |
4.249e-05 |
0.001412 |
140 |
INTRACELLULAR RECEPTOR SIGNALING PATHWAY |
7 |
168 |
4.249e-05 |
0.001412 |
141 |
INTRACELLULAR SIGNAL TRANSDUCTION |
22 |
1572 |
4.532e-05 |
0.001496 |
142 |
MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE |
3 |
13 |
4.57e-05 |
0.001497 |
143 |
DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE |
4 |
36 |
4.616e-05 |
0.001502 |
144 |
CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING |
5 |
71 |
4.678e-05 |
0.001512 |
145 |
NEGATIVE REGULATION OF NEURON DEATH |
7 |
171 |
4.755e-05 |
0.001526 |
146 |
REGULATION OF GROWTH |
13 |
633 |
4.943e-05 |
0.001575 |
147 |
NEURON PROJECTION DEVELOPMENT |
12 |
545 |
5.054e-05 |
0.0016 |
148 |
MACROMOLECULE CATABOLIC PROCESS |
16 |
926 |
5.143e-05 |
0.001617 |
149 |
POSITIVE REGULATION OF PROTEIN BINDING |
5 |
73 |
5.35e-05 |
0.001627 |
150 |
TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR |
5 |
73 |
5.35e-05 |
0.001627 |
151 |
CELL MATRIX ADHESION |
6 |
119 |
5.321e-05 |
0.001627 |
152 |
G1 DNA DAMAGE CHECKPOINT |
5 |
73 |
5.35e-05 |
0.001627 |
153 |
POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
6 |
119 |
5.321e-05 |
0.001627 |
154 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
23 |
1710 |
5.459e-05 |
0.001649 |
155 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
17 |
1036 |
5.575e-05 |
0.001663 |
156 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
17 |
1036 |
5.575e-05 |
0.001663 |
157 |
REGULATION OF WNT SIGNALING PATHWAY |
9 |
310 |
5.824e-05 |
0.001715 |
158 |
CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE |
3 |
14 |
5.792e-05 |
0.001715 |
159 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
12 |
554 |
5.914e-05 |
0.00172 |
160 |
REGULATION OF MITOTIC CELL CYCLE |
11 |
468 |
5.914e-05 |
0.00172 |
161 |
REGULATION OF ORGAN MORPHOGENESIS |
8 |
242 |
6.188e-05 |
0.001788 |
162 |
NEGATIVE REGULATION OF ENDOCYTOSIS |
4 |
39 |
6.363e-05 |
0.001816 |
163 |
NUCLEOTIDE EXCISION REPAIR DNA INCISION |
4 |
39 |
6.363e-05 |
0.001816 |
164 |
REGULATION OF CELL DIFFERENTIATION |
21 |
1492 |
6.415e-05 |
0.00182 |
165 |
REGULATION OF TRANSFERASE ACTIVITY |
16 |
946 |
6.622e-05 |
0.001867 |
166 |
REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS |
7 |
181 |
6.811e-05 |
0.001909 |
167 |
NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION |
4 |
40 |
7.04e-05 |
0.001961 |
168 |
REGULATION OF MAP KINASE ACTIVITY |
9 |
319 |
7.254e-05 |
0.002009 |
169 |
SOMITE DEVELOPMENT |
5 |
78 |
7.355e-05 |
0.002025 |
170 |
DNA REPAIR |
11 |
480 |
7.415e-05 |
0.002029 |
171 |
CELL ACTIVATION |
12 |
568 |
7.502e-05 |
0.002041 |
172 |
SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
6 |
127 |
7.648e-05 |
0.002045 |
173 |
REGULATION OF CELL CYCLE PHASE TRANSITION |
9 |
321 |
7.609e-05 |
0.002045 |
174 |
NEGATIVE REGULATION OF ION TRANSPORT |
6 |
127 |
7.648e-05 |
0.002045 |
175 |
MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS |
5 |
79 |
7.818e-05 |
0.002079 |
176 |
POSITIVE REGULATION OF LIPID METABOLIC PROCESS |
6 |
128 |
7.988e-05 |
0.002112 |
177 |
DNA GEOMETRIC CHANGE |
5 |
81 |
8.81e-05 |
0.002316 |
178 |
MESENCHYME DEVELOPMENT |
7 |
190 |
9.236e-05 |
0.002414 |
179 |
JNK CASCADE |
5 |
82 |
9.341e-05 |
0.002422 |
180 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
14 |
771 |
9.37e-05 |
0.002422 |
181 |
NEURON DIFFERENTIATION |
15 |
874 |
9.72e-05 |
0.002499 |
182 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
22 |
1656 |
9.812e-05 |
0.002507 |
183 |
REGULATION OF NEURON APOPTOTIC PROCESS |
7 |
192 |
9.86e-05 |
0.002507 |
184 |
REGULATION OF KINASE ACTIVITY |
14 |
776 |
0.0001003 |
0.002537 |
185 |
NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY |
4 |
44 |
0.0001028 |
0.002572 |
186 |
INTERSTRAND CROSS LINK REPAIR |
4 |
44 |
0.0001028 |
0.002572 |
187 |
MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS |
3 |
17 |
0.0001069 |
0.002646 |
188 |
MATURE B CELL DIFFERENTIATION |
3 |
17 |
0.0001069 |
0.002646 |
189 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
8 |
262 |
0.0001076 |
0.002648 |
190 |
POSITIVE REGULATION OF CELL CYCLE ARREST |
5 |
85 |
0.0001108 |
0.002714 |
191 |
ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE |
8 |
264 |
0.0001134 |
0.002762 |
192 |
ORGANONITROGEN COMPOUND METABOLIC PROCESS |
23 |
1796 |
0.0001152 |
0.00279 |
193 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
7 |
197 |
0.0001157 |
0.00279 |
194 |
NEGATIVE REGULATION OF MITOTIC CELL CYCLE |
7 |
199 |
0.0001232 |
0.002955 |
195 |
REGULATION OF CELL MATURATION |
3 |
18 |
0.0001278 |
0.003033 |
196 |
LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT |
3 |
18 |
0.0001278 |
0.003033 |
197 |
NEURON DEATH |
4 |
47 |
0.0001334 |
0.00315 |
198 |
B CELL DIFFERENTIATION |
5 |
89 |
0.0001378 |
0.003222 |
199 |
SEGMENTATION |
5 |
89 |
0.0001378 |
0.003222 |
200 |
PLASMA MEMBRANE ORGANIZATION |
7 |
203 |
0.0001394 |
0.003227 |
201 |
NEGATIVE REGULATION OF CATABOLIC PROCESS |
7 |
203 |
0.0001394 |
0.003227 |
202 |
RESPONSE TO EXTERNAL STIMULUS |
23 |
1821 |
0.0001417 |
0.003248 |
203 |
FC EPSILON RECEPTOR SIGNALING PATHWAY |
6 |
142 |
0.0001415 |
0.003248 |
204 |
POSITIVE REGULATION OF WOUND HEALING |
4 |
48 |
0.0001449 |
0.003304 |
205 |
MUSCLE STRUCTURE DEVELOPMENT |
10 |
432 |
0.0001472 |
0.003341 |
206 |
CELLULAR MACROMOLECULE LOCALIZATION |
18 |
1234 |
0.0001481 |
0.003346 |
207 |
NEGATIVE REGULATION OF TRANSFERASE ACTIVITY |
9 |
351 |
0.0001496 |
0.003363 |
208 |
CELLULAR CARBOHYDRATE METABOLIC PROCESS |
6 |
144 |
0.0001528 |
0.003418 |
209 |
NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION |
6 |
146 |
0.0001647 |
0.003667 |
210 |
LYMPHOCYTE DIFFERENTIATION |
7 |
209 |
0.0001668 |
0.003697 |
211 |
REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
8 |
280 |
0.0001698 |
0.003714 |
212 |
MULTICELLULAR ORGANISM METABOLIC PROCESS |
5 |
93 |
0.0001695 |
0.003714 |
213 |
REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY |
4 |
50 |
0.00017 |
0.003714 |
214 |
REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
6 |
147 |
0.000171 |
0.003717 |
215 |
REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS |
6 |
148 |
0.0001774 |
0.003839 |
216 |
CELLULAR RESPONSE TO DNA DAMAGE STIMULUS |
13 |
720 |
0.0001792 |
0.003859 |
217 |
BIOLOGICAL ADHESION |
16 |
1032 |
0.0001813 |
0.003888 |
218 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
15 |
926 |
0.0001832 |
0.003911 |
219 |
POSITIVE REGULATION OF GENE EXPRESSION |
22 |
1733 |
0.0001892 |
0.004019 |
220 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
17 |
1152 |
0.0002015 |
0.004223 |
221 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
9 |
365 |
0.0002003 |
0.004223 |
222 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
21 |
1618 |
0.0002006 |
0.004223 |
223 |
POSITIVE REGULATION OF WNT SIGNALING PATHWAY |
6 |
152 |
0.000205 |
0.004278 |
224 |
PALLIUM DEVELOPMENT |
6 |
153 |
0.0002125 |
0.004413 |
225 |
NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
5 |
98 |
0.0002167 |
0.004481 |
226 |
LEUKOCYTE DIFFERENTIATION |
8 |
292 |
0.0002258 |
0.004648 |
227 |
NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS |
6 |
156 |
0.000236 |
0.004837 |
228 |
ENDOCARDIAL CUSHION MORPHOGENESIS |
3 |
22 |
0.0002373 |
0.004839 |
229 |
MITOTIC DNA INTEGRITY CHECKPOINT |
5 |
100 |
0.0002381 |
0.004839 |
230 |
TISSUE DEVELOPMENT |
20 |
1518 |
0.0002392 |
0.00484 |
231 |
NEGATIVE REGULATION OF CELL ADHESION |
7 |
223 |
0.0002481 |
0.004998 |
232 |
NEURON NEURON SYNAPTIC TRANSMISSION |
4 |
56 |
0.0002643 |
0.0053 |
233 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
13 |
750 |
0.0002663 |
0.005319 |
234 |
REGULATION OF NUCLEASE ACTIVITY |
3 |
23 |
0.0002717 |
0.005404 |
235 |
STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
5 |
103 |
0.0002733 |
0.005411 |
236 |
REGULATION OF CELL CYCLE PROCESS |
11 |
558 |
0.0002756 |
0.005433 |
237 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
10 |
470 |
0.0002896 |
0.005685 |
238 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
7 |
229 |
0.0002915 |
0.0057 |
239 |
REGULATION OF CYTOKINE PRODUCTION |
11 |
563 |
0.0002973 |
0.005764 |
240 |
RESPONSE TO WOUNDING |
11 |
563 |
0.0002973 |
0.005764 |
241 |
REGULATION OF DEFENSE RESPONSE |
13 |
759 |
0.0002987 |
0.005768 |
242 |
REGULATION OF MAPK CASCADE |
12 |
660 |
0.0003021 |
0.005809 |
243 |
CELL SUBSTRATE ADHESION |
6 |
164 |
0.0003088 |
0.005874 |
244 |
CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION |
3 |
24 |
0.0003093 |
0.005874 |
245 |
REGULATION OF EXECUTION PHASE OF APOPTOSIS |
3 |
24 |
0.0003093 |
0.005874 |
246 |
INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY |
5 |
106 |
0.0003122 |
0.005905 |
247 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
14 |
867 |
0.0003152 |
0.005938 |
248 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
13 |
767 |
0.0003303 |
0.006197 |
249 |
PEPTIDE METABOLIC PROCESS |
11 |
571 |
0.0003351 |
0.006262 |
250 |
REGULATION OF PEPTIDASE ACTIVITY |
9 |
392 |
0.0003387 |
0.006305 |
251 |
IN UTERO EMBRYONIC DEVELOPMENT |
8 |
311 |
0.0003449 |
0.006393 |
252 |
REGULATION OF ESTABLISHMENT OF PLANAR POLARITY |
5 |
110 |
0.0003705 |
0.006816 |
253 |
IMMUNE RESPONSE |
16 |
1100 |
0.0003706 |
0.006816 |
254 |
SCHWANN CELL DEVELOPMENT |
3 |
26 |
0.0003941 |
0.00722 |
255 |
RESPONSE TO HORMONE |
14 |
893 |
0.0004241 |
0.007738 |
256 |
NEURON DEVELOPMENT |
12 |
687 |
0.0004332 |
0.007874 |
257 |
DEFENSE RESPONSE |
17 |
1231 |
0.0004359 |
0.007875 |
258 |
GLIOGENESIS |
6 |
175 |
0.0004366 |
0.007875 |
259 |
RESPONSE TO STEROID HORMONE |
10 |
497 |
0.0004494 |
0.008074 |
260 |
REGULATION OF ION TRANSPORT |
11 |
592 |
0.0004541 |
0.008127 |
261 |
POSITIVE REGULATION OF CELL CYCLE PROCESS |
7 |
247 |
0.0004595 |
0.008193 |
262 |
REGULATION OF METAL ION TRANSPORT |
8 |
325 |
0.000462 |
0.008204 |
263 |
CELL PROJECTION ORGANIZATION |
14 |
902 |
0.0004686 |
0.00829 |
264 |
REGULATION OF AUTOPHAGY |
7 |
249 |
0.0004822 |
0.008499 |
265 |
PLACENTA BLOOD VESSEL DEVELOPMENT |
3 |
28 |
0.0004926 |
0.008617 |
266 |
AUDITORY RECEPTOR CELL DIFFERENTIATION |
3 |
28 |
0.0004926 |
0.008617 |
267 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
4 |
66 |
0.000497 |
0.008628 |
268 |
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
4 |
66 |
0.000497 |
0.008628 |
269 |
NEGATIVE REGULATION OF PROTEOLYSIS |
8 |
329 |
0.0005008 |
0.008662 |
270 |
LEUKOCYTE ACTIVATION |
9 |
414 |
0.0005031 |
0.00867 |
271 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
16 |
1135 |
0.0005223 |
0.008968 |
272 |
POSITIVE REGULATION OF NEURON DEATH |
4 |
67 |
0.0005263 |
0.009003 |
273 |
POSITIVE REGULATION OF CELL CYCLE |
8 |
332 |
0.0005316 |
0.009061 |
274 |
PATTERN SPECIFICATION PROCESS |
9 |
418 |
0.0005391 |
0.009154 |
275 |
ENDOCYTOSIS |
10 |
509 |
0.0005411 |
0.009155 |
276 |
RESPONSE TO ARSENIC CONTAINING SUBSTANCE |
3 |
29 |
0.0005473 |
0.009226 |
277 |
MULTI ORGANISM TRANSPORT |
4 |
68 |
0.0005568 |
0.009303 |
278 |
POSITIVE REGULATION OF LOCOMOTION |
9 |
420 |
0.0005578 |
0.009303 |
279 |
MULTI ORGANISM LOCALIZATION |
4 |
68 |
0.0005568 |
0.009303 |
280 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
10 |
513 |
0.0005749 |
0.009553 |
281 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
8 |
337 |
0.0005864 |
0.009675 |
282 |
POSITIVE REGULATION OF DNA METABOLIC PROCESS |
6 |
185 |
0.0005856 |
0.009675 |